Immunoglobuline Humaine De L'hepatite B Lfb

Human Hepatitis B Immunoglobulin, the active ingredient in Immunoglobuline Humaine De L'hepatite B Lfb, is an immunoglobulin presented as a sterile injectable solution for intramuscular use. It provides passive immunity to prevent hepatitis B virus infection in at‑risk individuals. GNH USA supplies Immunoglobuline Humaine De L'hepatite B Lfb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

Human Hepatitis B Immunoglobulin is used within the antiviral and hepatitis B prophylaxis pathway to prevent HBV infection and recurrence. - Post‑exposure prophylaxis: provides immediate passive immunity to avert hepatitis B infection after potential exposure. - Liver transplantation: prevents recurrence of hepatitis B in recipients of HBV‑positive donor livers. - Neonatal protection: administered to newborns of HBsAg‑positive mothers to block perinatal transmission of hepatitis B.

Human Hepatitis B Immunoglobulin may cause adverse reactions following intramuscular administration.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Fever: transient low‑grade temperature elevation. - Headache: occasional mild headache. - Fatigue: short‑term tiredness. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Serum sickness‑like reaction: fever, rash, arthralgia occurring days after administration. - Thrombocytopenia: reduced platelet count, potentially leading to bleeding. - Guillain‑Barré syndrome: rare demyelinating neuropathy. - Severe local tissue necrosis: extensive tissue damage at injection site.

Human Hepatitis B Immunoglobulin should be used with careful clinical assessment. - Serology assessment: confirm HBV status and anti‑HBs titres before administration. - Allergy screening: avoid in patients with known hypersensitivity to human immunoglobulins. - Monitor reactions: observe for signs of anaphylaxis or serum sickness after injection. - Caution in immunocompromised: efficacy may be reduced; monitor virologic response. - Do not inject intravenously: intended for intramuscular use only. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Human Hepatitis B Immunoglobulin can interact with other therapies, influencing safety or efficacy.

Major Interactions (Avoid): - Concurrent blood products: may increase risk of volume overload. - Live vaccines: immunoglobulin may diminish vaccine efficacy. - Serologic testing: can interfere with hepatitis B surface antigen assays.

Moderate Interactions (Monitor Closely): - Anticoagulants: potential for altered bleeding risk. - Immunosuppressants: may affect immunoglobulin clearance and response. - Other vaccines: schedule administration to avoid reduced immunogenicity.